O2Bio Posts Strong Growth and Preps for Next-Phase Expansion
Late in 2024 and early 2025, O2Bio marked major milestones in both financial growth and R&D positioning—evidencing its rising prominence in the clean-tech and biotech sectors. Robust Financial Results for FY 2024 O2Bio announced a total revenue of ₩198 billion and a net profit of ₩16 billion in its 2024 fiscal results. This represents a 33% increase […]
Evolving Needs in the Medical Industry—and How O2Bio Is Answering the Call
The global medical industry is undergoing a profound transformation. From the rise of home-based care to the need for more mobile and decentralized solutions, healthcare systems are being pushed to adapt faster than ever before. As populations age and chronic diseases like COPD and lung cancer become more prevalent, the demand for accessible, patient-centered medical […]
How Government R&D is Powering O2Bio’s Breakthrough in Gas Generation
In the competitive landscape of clean tech and medical devices, early-stage companies often face an uphill battle—balancing product development, funding, and credibility. But for O2Bio, a Korean startup specializing in oxygen and nitrogen generation systems, strategic support from government-backed R&D programs is helping them fast-track innovation and gain trust in the market. Since its founding […]
Redefining Clean Air Technology Through Smart Gas Generation
In a world where access to clean air is increasingly critical across industries, O2Bio is emerging as a promising startup at the forefront of portable, high-purity oxygen and nitrogen generation. Founded in 2023 in Gimhae, South Korea, O2Bio was built on a bold vision: to make essential gases more accessible, affordable, and efficient for medical, […]